Papers associated with gabarap

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 8 9 10 11 12 13 ???pagination.result.next???

Sort Newest To Oldest

Sort Oldest To Newest

referenced by:

	Inhibition by miltirone of up-regulation of GABAA receptor alpha4 subunit mRNA by ethanol withdrawal in hippocampal neurons., Mostallino MC, Mascia MP, Pisu MG, Busonero F, Talani G, Biggio G., Eur J Pharmacol. June 28, 2004; 494 (2-3): 83-90.
	Gamma-aminobutyric acidA receptors do not mediate the immobility produced by isoflurane., Zhang Y, Sonner JM, Eger EI, Stabernack CR, Laster MJ, Raines DE, Harris RA., Anesth Analg. July 1, 2004; 99 (1): 85-90.
	Slow actions of neuroactive steroids at GABAA receptors., Shu HJ, Eisenman LN, Jinadasa D, Covey DF, Zorumski CF, Mennerick S., J Neurosci. July 28, 2004; 24 (30): 6667-75.
	Fragrances in oolong tea that enhance the response of GABAA receptors., Hossain SJ, Aoshima H, Koda H, Kiso Y., Biosci Biotechnol Biochem. September 1, 2004; 68 (9): 1842-8.
	Modulation of human GABAA and glycine receptor currents by menthol and related monoterpenoids., Hall AC, Turcotte CM, Betts BA, Yeung WY, Agyeman AS, Burk LA., Eur J Pharmacol. December 3, 2004; 506 (1): 9-16.
	A novel pharmatope tag inserted into the beta4 subunit confers allosteric modulation to neuronal nicotinic receptors., Sanders T, Hawrot E., J Biol Chem. December 3, 2004; 279 (49): 51460-5.
	Subunit-specific coupling between gamma-aminobutyric acid type A and P2X2 receptor channels., Boué-Grabot E, Toulmé E, Emerit MB, Garret M., J Biol Chem. December 10, 2004; 279 (50): 52517-25.
	Mutation of glutamate 155 of the GABAA receptor beta2 subunit produces a spontaneously open channel: a trigger for channel activation., Newell JG, McDevitt RA, Czajkowski C., J Neurosci. December 15, 2004; 24 (50): 11226-35.
	Functional and structural analysis of the GABAA receptor alpha 1 subunit during channel gating and alcohol modulation., Jung S, Akabas MH, Harris RA., J Biol Chem. January 7, 2005; 280 (1): 308-16.
	BDNF modulates GABAA receptors microtransplanted from the human epileptic brain to Xenopus oocytes., Palma E, Torchia G, Limatola C, Trettel F, Arcella A, Cantore G, Di Gennaro G, Manfredi M, Esposito V, Quarato PP, Miledi R, Eusebi F., Proc Natl Acad Sci U S A. February 1, 2005; 102 (5): 1667-72.
	Abnormal GABAA receptors from the human epileptic hippocampal subiculum microtransplanted to Xenopus oocytes., Palma E, Spinelli G, Torchia G, Martinez-Torres A, Ragozzino D, Miledi R, Eusebi F., Proc Natl Acad Sci U S A. February 15, 2005; 102 (7): 2514-8.
	Classic benzodiazepines modulate the open-close equilibrium in alpha1beta2gamma2L gamma-aminobutyric acid type A receptors., Rüsch D, Forman SA., Anesthesiology. April 1, 2005; 102 (4): 783-92.
	New evidence that both T-type calcium channels and GABAA channels are responsible for the potent peripheral analgesic effects of 5alpha-reduced neuroactive steroids., Pathirathna S, Brimelow BC, Jagodic MM, Krishnan K, Jiang X, Zorumski CF, Mennerick S, Covey DF, Todorovic SM, Jevtovic-Todorovic V., Pain. April 1, 2005; 114 (3): 429-443.
	Ethyl 2-(4-bromophenyl)-1-(2,4-dichlorophenyl)-1H-4-imidazolecarboxylate is a novel positive modulator of GABAA receptors., Mascia MP, Asproni B, Busonero F, Talani G, Maciocco E, Pau A, Cerri R, Sanna E, Biggio G., Eur J Pharmacol. June 15, 2005; 516 (3): 204-11.
	Single-amino-acid difference in the sequence of alpha6 subunit dramatically increases the ethanol sensitivity of recombinant GABAA receptors., Valenzuela CF, Mameli M, Carta M., Alcohol Clin Exp Res. July 1, 2005; 29 (7): 1356-7; author reply 1358.
	GABAA receptor-associated protein regulates GABAA receptor cell-surface number in Xenopus laevis oocytes., Chen ZW, Chang CS, Leil TA, Olcese R, Olsen RW., Mol Pharmacol. July 1, 2005; 68 (1): 152-9.
	Selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcohol., Cook JB, Foster KL, Eiler WJ, McKay PF, Woods J, Harvey SC, Garcia M, Grey C, McCane S, Mason D, Cummings R, Li X, Cook JM, June HL., Alcohol Clin Exp Res. August 1, 2005; 29 (8): 1390-401.
	Novel plant substances acting as beta subunit isoform-selective positive allosteric modulators of GABAA receptors., Baur R, Simmen U, Senn M, Séquin U, Sigel E., Mol Pharmacol. September 1, 2005; 68 (3): 787-92.
	Protons inhibit Cl- conductance by direct or allosteric interaction with the GABA-binding site in the rat recombinant alpha1beta2gamma2L and alpha1beta2 GABAA receptor., Wang MD, Rahman M, Zhu D., Eur J Pharmacol. December 28, 2005; 528 (1-3): 1-6.
	Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types., Moroni M, Bermudez I., J Mol Neurosci. January 1, 2006; 30 (1-2): 95-6.
	Impact of epsilon and theta subunits on pharmacological properties of alpha3beta1 GABAA receptors expressed in Xenopus oocytes., Ranna M, Sinkkonen ST, Möykkynen T, Uusi-Oukari M, Korpi ER., BMC Pharmacol. January 13, 2006; 6 1.
	Pharmacological properties of GABAA receptors containing gamma1 subunits., Khom S, Baburin I, Timin EN, Hohaus A, Sieghart W, Hering S., Mol Pharmacol. February 1, 2006; 69 (2): 640-9.
	Charged residues in the alpha1 and beta2 pre-M1 regions involved in GABAA receptor activation., Mercado J, Czajkowski C., J Neurosci. February 15, 2006; 26 (7): 2031-40.
	An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition., Dawson GR, Maubach KA, Collinson N, Cobain M, Everitt BJ, MacLeod AM, Choudhury HI, McDonald LM, Pillai G, Rycroft W, Smith AJ, Sternfeld F, Tattersall FD, Wafford KA, Reynolds DS, Seabrook GR, Atack JR., J Pharmacol Exp Ther. March 1, 2006; 316 (3): 1335-45.
	Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2., Stórustovu SI, Ebert B., J Pharmacol Exp Ther. March 1, 2006; 316 (3): 1351-9.
	An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability., Barela AJ, Waddy SP, Lickfett JG, Hunter J, Anido A, Helmers SL, Goldin AL, Escayg A., J Neurosci. March 8, 2006; 26 (10): 2714-23.
	Contributions of the GABAA receptor alpha6 subunit to phasic and tonic inhibition revealed by a naturally occurring polymorphism in the alpha6 gene., Santhakumar V, Hanchar HJ, Wallner M, Olsen RW, Otis TS., J Neurosci. March 22, 2006; 26 (12): 3357-64.
	State-dependent cross-linking of the M2 and M3 segments: functional basis for the alignment of GABAA and acetylcholine receptor M3 segments., Jansen M, Akabas MH., J Neurosci. April 26, 2006; 26 (17): 4492-9.
	Depolarizing GABAergic conductances regulate the balance of excitation to inhibition in the developing retinotectal circuit in vivo., Akerman CJ, Cline HT., J Neurosci. May 10, 2006; 26 (19): 5117-30.
	Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy., Serantes R, Arnalich F, Figueroa M, Salinas M, Andrés-Mateos E, Codoceo R, Renart J, Matute C, Cavada C, Cuadrado A, Montiel C., J Biol Chem. May 26, 2006; 281 (21): 14632-43.
	Low-dose alcohol actions on alpha4beta3delta GABAA receptors are reversed by the behavioral alcohol antagonist Ro15-4513., Wallner M, Hanchar HJ, Olsen RW., Proc Natl Acad Sci U S A. May 30, 2006; 103 (22): 8540-5.
	Neurosteroid analogues. 11. Alternative ring system scaffolds: gamma-aminobutyric acid receptor modulation and anesthetic actions of benz[f]indenes., Scaglione JB, Manion BD, Benz A, Taylor A, DeKoster GT, Rath NP, Evers AS, Zorumski CF, Mennerick S, Covey DF., J Med Chem. July 27, 2006; 49 (15): 4595-605.
	Mechanism of action of benzodiazepines on GABAA receptors., Campo-Soria C, Chang Y, Weiss DS., Br J Pharmacol. August 1, 2006; 148 (7): 984-90.
	Synthesis of trifluoromethylaryl diazirine and benzophenone derivatives of etomidate that are potent general anesthetics and effective photolabels for probing sites on ligand-gated ion channels., Husain SS, Nirthanan S, Ruesch D, Solt K, Cheng Q, Li GD, Arevalo E, Olsen RW, Raines DE, Forman SA, Cohen JB, Miller KW., J Med Chem. August 10, 2006; 49 (16): 4818-25.
	The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated., Atack JR, Bayley PJ, Fletcher SR, McKernan RM, Wafford KA, Dawson GR., Eur J Pharmacol. October 24, 2006; 548 (1-3): 77-82.
	The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors., Popik P, Kostakis E, Krawczyk M, Nowak G, Szewczyk B, Krieter P, Chen Z, Russek SJ, Gibbs TT, Farb DH, Skolnick P, Lippa AS, Basile AS., J Pharmacol Exp Ther. December 1, 2006; 319 (3): 1244-52.
	Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptor., Sedelnikova A, Erkkila BE, Harris H, Zakharkin SO, Weiss DS., J Physiol. December 1, 2006; 577 (Pt 2): 569-77.
	Imaging GABAc receptors with ligand-conjugated quantum dots., Tomlinson ID, Gussin HA, Little DM, Warnement MR, Qian H, Pepperberg DR, Rosenthal SJ., J Biomed Biotechnol. January 1, 2007; 2007 76514.
	Agonist-, antagonist-, and benzodiazepine-induced structural changes in the alpha1 Met113-Leu132 region of the GABAA receptor., Kloda JH, Czajkowski C., Mol Pharmacol. February 1, 2007; 71 (2): 483-93.
	The location of a closed channel gate in the GABAA receptor channel., Bali M, Akabas MH., J Gen Physiol. February 1, 2007; 129 (2): 145-59.
	Changes in the function of the inhibitory neurotransmitter system in the rat brain following subchronic inhalation exposure to 1-bromopropane., Ueno S, Yoshida Y, Fueta Y, Ishidao T, Liu J, Kunugita N, Yanagihara N, Hori H., Neurotoxicology. March 1, 2007; 28 (2): 415-20.
	4-aryl-5-(4-piperidyl)-3-isoxazolol GABAA antagonists: synthesis, pharmacology, and structure-activity relationships., Frølund B, Jensen LS, Storustovu SI, Stensbøl TB, Ebert B, Kehler J, Krogsgaard-Larsen P, Liljefors T., J Med Chem. April 19, 2007; 50 (8): 1988-92.
	Modulation of GABAA receptors in cerebellar granule neurons by ethanol: a review of genetic and electrophysiological studies., Botta P, Radcliffe RA, Carta M, Mameli M, Daly E, Floyd KL, Deitrich RA, Valenzuela CF., Alcohol. May 1, 2007; 41 (3): 187-99.
	Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators., Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW., Proc Natl Acad Sci U S A. May 8, 2007; 104 (19): 8059-64.
	Rat alpha6beta2delta GABAA receptors exhibit two distinct and separable agonist affinities., Hadley SH, Amin J., J Physiol. June 15, 2007; 581 (Pt 3): 1001-18.
	C-terminal modification is required for GABARAP-mediated GABA(A) receptor trafficking., Chen ZW, Chang CS, Leil TA, Olsen RW., J Neurosci. June 20, 2007; 27 (25): 6655-63.
	Electrophysiological properties and subunit composition of GABAA receptors in patients with gelastic seizures and hypothalamic hamartoma., Wu J, Chang Y, Li G, Xue F, DeChon J, Ellsworth K, Liu Q, Yang K, Bahadroani N, Zheng C, Zhang J, Rekate H, Rho JM, Kerrigan JF., J Neurophysiol. July 1, 2007; 98 (1): 5-15.
	Transducing agonist binding to channel gating involves different interactions in 5-HT3 and GABAC receptors., Price KL, Millen KS, Lummis SC., J Biol Chem. August 31, 2007; 282 (35): 25623-30.
	The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation., Palma E, Ragozzino D, Di Angelantonio S, Mascia A, Maiolino F, Manfredi M, Cantore G, Esposito V, Di Gennaro G, Quarato P, Miledi R, Eusebi F., Epilepsia. October 1, 2007; 48 (10): 1842-9.
	Neuroactive steroids and human recombinant rho1 GABAC receptors., Li W, Jin X, Covey DF, Steinbach JH., J Pharmacol Exp Ther. October 1, 2007; 323 (1): 236-47.

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 8 9 10 11 12 13 ???pagination.result.next???